Profil

Henket Monique

GIGA I3 - Pneumology

See author's contact details
Main Referenced Co-authors
Louis, Renaud  (137)
Schleich, FLorence  (83)
Guiot, Julien  (50)
Paulus, Virginie  (44)
Guissard, Françoise  (41)
Main Referenced Keywords
Humans (19); Asthma (18); sputum (12); asthma (9); Biomarkers (9);
Main Referenced Unit & Research Centers
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège (2)
OBiAChem (2)
CHU (1)
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (1)
Centre Interfacultaire de Recherche du Médicament - CIRM (1)
Main Referenced Disciplines
Cardiovascular & respiratory systems (89)
Chemistry (27)
Public health, health care sciences & services (9)
Immunology & infectious disease (7)
Biochemistry, biophysics & molecular biology (5)

Publications (total 149)

The most downloaded
1075 downloads
Moermans, C., HEINEN, V., NGUYEN DANG, D., HENKET, M., SELE, J., Manise, M., Corhay, J.-L., & Louis, R. (2011). Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine, 56 (2), 298-304. doi:10.1016/j.cyto.2011.07.010 https://hdl.handle.net/2268/104859

The most cited

452 citations (Scopus®)

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x https://hdl.handle.net/2268/260539

Schleich, F., Moermans, C., Seidel, L., Kempeneers, C., Louis, G., ROGISTER, F., Tombu, S., Pottier, L., Poirrier, A.-L., ZIANT, S., Henket, M., SANCHEZ, C., PAULUS, V., GUISSARD, F., Donneau, A.-F., & Louis, R. (November 2023). Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction - PROMISE. ERJ Open Research, 9 (6). doi:10.1183/23120541.00383-2023
Peer Reviewed verified by ORBi

Dejong, T., Hansen, M., Bertrand, V., Zanella, D., Henket, M., Massenet, T., Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (October 2023). Une approche GC×GC-MS pour mieux comprendre les phénomènes inflammatoires au niveau moléculaire [Paper presentation]. "Coup de Jeune(s) sur la chromatographie", Lyon, France.

Schleich, F., Moermans, C., Gerday, S., ZIANT, S., Louis, G., Bougard, N., PAULUS, V., GUISSARD, F., Henket, M., Bachert, C., & Louis, R. (October 2023). Patients With Asthma Only Sensitized to Staphylococcus aureus Enterotoxins Have More Exacerbations, Airflow Limitation, and Higher Levels of Sputum IL-5 and IgE. Journal of Allergy and Clinical Immunology: In Practice, 11 (10), 3055-3061.e4. doi:10.1016/j.jaip.2023.05.043
Peer Reviewed verified by ORBi

Gerday, S., Graff, S., Moermans, C., GUISSARD, F., PAULUS, V., Henket, M., Louis, R., & Schleich, F. (2023). Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline. Thorax, 2022-219781. doi:10.1136/thorax-2022-219781
Peer Reviewed verified by ORBi

Massenet, T., Potjewijd, J., Henket, M., Gridelet, G., Zanella, D., Dejong, T., GILTAY, L., GESTER, F., GUISSARD, F., André, B., Ribbens, C., Van Paassen, P., Louis, R., Focant, J.-F., Guiot, J.* , & Stefanuto, P.-H.*. (20 June 2023). Breath analysis to diagnose and assess systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry [Poster presentation]. Metabolomics 2023, Niagara Falls, Canada.
* These authors have contributed equally to this work.

Zahraei, H. N., Schleich, F., Gerday, S., GUISSARD, F., PAULUS, V., Henket, M., Moermans, C., Donneau, A.-F.* , & Louis, R.*. (June 2023). A clustering analysis of eosinophilic asthmatics: Two clusters with sharp differences in atopic status and disease severity. Clinical and Experimental Allergy, 53 (6), 672-678. doi:10.1111/cea.14312
Peer reviewed
* These authors have contributed equally to this work.

Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6
Peer Reviewed verified by ORBi

Massenet, T., Guiot, J., Zanella, D., Dejong, T., GILTAY, L., Henket, M., GUISSARD, F., André, B., Malaise, M., Potjewijd Judith, Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (29 March 2023). Etude métabolomique de l’air exhalé pour diagnostiquer la sclérodermie systémique par chromatographie gazeuse bidimensionnelle exhaustive [Paper presentation]. SEP 23, Paris, France.

Guiot, J., Henket, M., Ernst, M., Seidel, L., WINANDY, M.-L., DENIS, A., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., Garah, O., Njock, M.-S., CANIVET, P., Meunier, P., Corhay, J.-L., Regnier, C., Malaise, O., Malaise, M., & Louis, R. (09 March 2023). Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis. Frontiers in Medicine, 10. doi:10.3389/fmed.2023.1063012
Peer Reviewed verified by ORBi

Moermans, C., Brion, C., BOCK, G., Graff, S., Gerday, S., Nekoee, H., Poulet, C., Bricmont, N., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Schleich, F. (2023). Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5. CHEST. doi:10.1016/j.chest.2023.01.037
Peer Reviewed verified by ORBi

Louis, G., Pétré, B., Schleich, F., Zahrei, H. N., Donneau, A.-F., Henket, M., PAULUS, V., GUISSARD, F., Guillaume, M., & Louis, R. (2023). Predictors of change in asthma-related quality of life: a longitudinal real-life study in adult asthmatics. Quality of Life Research. doi:10.1007/s11136-022-03339-0
Peer Reviewed verified by ORBi

Dejong, T., Hansen, M., Bertrand, V., Zanella, D., Henket, M., Massenet, T., Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (2023). Volatolomic approach to characterise oxidative stress at the molecular level using in vitro models [Paper presentation]. SEP23, Paris, France.

Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., Louis, R., & Focant, J.-F. (2023). A Journey over Current Usage of GC×GC -TOFMS in Metabolomic [Paper presentation]. GCxGC & GCTOF metabonomics Webinar.

Louis, G., Schleich, F., Guillaume, M., Kirkove, D., Zahrei, H., Donneau, A.-F., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Pétré, B. (2023). Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis. ERJ Open Research, 00451-2022. doi:10.1183/23120541.00451-2022
Peer Reviewed verified by ORBi

Dejong, T., Hansen, M., Bertrand, V., Zanella, D., Henket, M., Massenet, T., Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (2023). Volatolomic approach to characterise oxidative stress at the molecular level using in vitro models [Paper presentation]. École thématique afsep vichy, Vichy, France.

Dejong, T., Hansen, M., Bertrand, V., Zanella, D., Henket, M., Massenet, T., Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (2023). Volatolomic Approach to Characterise Oxidative Stress at the Molecular Level Using in vitro Models [Paper presentation]. Metabolomics 2023, Niagara Falls, Canada.

DENIS, A., Henket, M., Ernst, M., Maes, N., THYS, M., Regnier, C., Malaise, O., Frix, A.-N., GESTER, F., DESIR, C., Meunier, P., Louis, R., Malaise, M., & Guiot, J. (30 November 2022). Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.1024298
Peer Reviewed verified by ORBi

Zanella, D., Henket, M., Dejong, T., Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (November 2022). Induced inflammation on in vitro lung model [Paper presentation]. Breath Biopsy Conference 2022, United Kingdom.
Editorial reviewed

Cambier, M., Muller, F., Henket, M., Remacle, C., Guiot, J., & Struman, I. (04 September 2022). Extracellular vesicles (EVs) as diagnostic tools in the phenotypic determination of lung tumors [Paper presentation]. ERS International Congress 2022, Barcelone, Spain. doi:10.1183/13993003.congress-2022.1370

Denis, A., Regnier, C., Henket, M., Maes, N., THYS, M., Louis, R., Malaise, M., & Guiot, J. (September 2022). Airflow obstruction as a marker of prognosis in rheumatoid arthritis [Poster presentation]. ERS International Congress 2022, Barcelone, Spain. doi:10.1183/13993003.congress-2022.2411

Guiot, J., Maes, N., WINANDY, M.-L., Henket, M., Ernst, B., THYS, M., Frix, A.-N., Morimont, P., Rousseau, A.-F., CANIVET, P., Louis, R., Misset, B., Meunier, P., Charbonnier, J.-P., & Lambermont, B. (29 August 2022). Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.930055
Peer Reviewed verified by ORBi

De Niet, S., Trémège, M., Coffiner, M., Rousseau, A.-F., CALMES, D., Frix, A.-N., GESTER, F., Delvaux, M., DIVE, A.-F., GUGLIELMI, E., Henket, M., Staderoli, A., Maesen, D., Louis, R., Guiot, J., & Cavalier, E. (26 July 2022). Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 14 (15), 3048. doi:10.3390/nu14153048
Peer Reviewed verified by ORBi

Esposito, G., Ernst, B., Henket, M., WINANDY, M.-L., Chatterjee, A., Van Eyndhoven, S., Praet, J., Smeets, D., MEUNIER, P., LOUIS, R., KOLH, P., & Guiot, J. (01 July 2022). AI-Based Chest CT Analysis for Rapid COVID-19 Diagnosis and Prognosis: A Practical Tool to Flag High-Risk Patients and Lower Healthcare Costs. Diagnostics, 12 (7), 1608. doi:10.3390/diagnostics12071608
Peer Reviewed verified by ORBi

CANIVET, P., DESIR, C., THYS, M., Henket, M., Frix, A.-N., Ernst, B., Walsh, S., Occhipinti, M., Vos, W., Maes, N., Canivet, J. L., LOUIS, R., MEUNIER, P., & Guiot, J. (28 June 2022). The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave. Diagnostics, 12 (7), 1567. doi:10.3390/diagnostics12071567
Peer Reviewed verified by ORBi

Gerday, S., SCHLEICH, F., Henket, M., GUISSARD, F., PAULUS, V., & LOUIS, R. (01 June 2022). Revisiting differences between atopic and non-atopic asthmatics: When age is shaping airway inflammatory profile. World Allergy Organization Journal, 15 (6), 100655. doi:10.1016/j.waojou.2022.100655
Peer Reviewed verified by ORBi

Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Judith Potjewijd, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (18 May 2022). BREATHOMICS APPROACH TO INVESTIGATE SYSTEMIC SCLEROSIS USING THERMAL DESORPTION AND COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY HIGH-RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETRY [Poster presentation]. 17th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-17), Gand, Belgium.

Gerday, S., Henket, M., GUISSARD, F., PAULUS, V., Louis, R., & Schleich, F. (17 May 2022). Super responders to mepolizumab are characterized by high sputum eosinophils and FeNO at baseline [Poster presentation]. ATS International Conference, San Francisco, United States.

Louis, G., Pétré, B., SCHLEICH, F., Nekoee Zahraei, H., Donneau, A.-F., HENKET, M., PAULUS, V., GUISSARD, F., Guillaume, M., & LOUIS, R. (2022). A Real Life Longitudinal Study on Asthma-Related Quality of Life in a Secondary Care Center. American Journal of Respiratory and Critical Care Medicine. doi:10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1334
Peer Reviewed verified by ORBi

Nekoee Zahraei, H., SCHLEICH, F., HENKET, M., PAULUS, V., Gerday, S., GUISSARD, F., Donneau, A.-F., & LOUIS, R. (15 May 2022). A clustering analysis of eosinophilic asthmatics [Paper presentation]. The American Thoracic Society International Conference ATS, San Francisco, United States - California.
Editorial reviewed

Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., DiGiovanni, N., GILTAY, L., HENKET, M., GUISSARD, F., SCHLEICH, F., GUIOT, J., ANDRE, B., MALAISE, M., Potjewijd, J., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (May 2022). Recent advances in medical applications of GC×GC [Paper presentation]. HTC-17, Ghent, Belgium.
Peer reviewed

Schleich, F., Graff, S., Bougard, N., Frix, A.-N., Peerboom, S., Demarche, S., GUISSARD, F., PAULUS, V., Henket, M., CALMES, D., Moermans, C., & Louis, R. (May 2022). L’asthme bronchique en pratique clinique : des phénotypes inflammatoires au traitement personnalisé. Revue Médicale de Liège, 77 (5-6), 289-294.
Editorial Reviewed verified by ORBi

GUIOT, J., HENKET, M., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., DESIR, C., MOERMANS, C., NJOCK, M.-S., MEUNIER, P., CORHAY, J.-L., & LOUIS, R. (11 April 2022). Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ? Respiratory Research, 23 (1), 89. doi:10.1186/s12931-022-02006-9
Peer Reviewed verified by ORBi

Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd Judith, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (01 February 2022). TD-GC×GC-HRTOFMS to investigate pulmonary fibrosis in patients [Poster presentation]. Multidimensional Chromatography Worshop 2022.

Cambier, M., Henket, M., Frix, A.-N., Gofflot, S., THYS, M., Tomasetti, S., Peired, A., Struman, I., Rousseau, A.-F., Misset, B., Darcis, G., Moutschen, M., Louis, R., Njock, M.-S., Cavalier, E., & Guiot, J. (2022). Increased KL-6 levels in moderate to severe COVID-19 infection. PLoS ONE, 17 (11), 0273107. doi:10.1371/journal.pone.0273107
Peer Reviewed verified by ORBi

Van Hulst, G., Jorssen, J., Jacobs, N., Henket, M., Louis, R., Schleich, F., Bureau, F., & Desmet, C. (2022). Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma. European Respiratory Journal. doi:10.1183/13993003.00935-2021
Peer Reviewed verified by ORBi

Van Hulst, G., Jorssen, J., Jacobs, N., Henket, M., Louis, R., Schleich, F., Bureau, F., & Desmet, C. (2022). Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance. European Respiratory Journal, 60 (1). doi:10.1183/13993003.00981-2022
Peer Reviewed verified by ORBi

Focant, J.-F., Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di Giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., & Louis, R. (2022). Exploring Volatolomes with GC×GC-TOFMS [Paper presentation]. Analytics Nantes 2022, Nantes, France.
Peer reviewed

Sibille, A., Henket, M., Corhay, J.-L., ALFIERI, R., Louis, R., & Duysinx, B. (October 2021). White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer. Lung, 199 (5), 549-557. doi:10.1007/s00408-021-00474-2
Peer Reviewed verified by ORBi

Louis, G., SCHLEICH, F., Guillaume, M., Donneau, A.-F., Nekoee Zahraei, H., HENKET, M., PAULUS, V., GUISSARD, F., Louis, R., & Pétré, B. (05 September 2021). Are asthma symptom intensity scales better than biomarkers for diagnosing asthma? A prospective observational study [Poster presentation]. ERS International Congress 2021 (Virtual).

Louis, G., Pétré, B., SCHLEICH, F., Nekoee Zahraei, H., Donneau, A.-F., Silvestre, A., HENKET, M., PAULUS, V., GUISSARD, F., Guillaume, M., & Louis, R. (2021). Predictors of asthma-related quality of life in a large cohort of asthmatics : A cross-sectional study in a secondary care center. Clinical and Translational Allergy. doi:10.1002/clt2.12054
Peer Reviewed verified by ORBi

Denis, A., Henket, M., GESTER, F., THYS, M., Ernst, M., Maes, N., GILTAY, L., Frix, A.-N., Maloir, Q., Meunier, P., DESIR, C., Louis, R., & Guiot, J. (September 2021). Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study [Poster presentation]. ERS International Congress 2021. doi:10.1183/13993003.congress-2021.PA2542

Zanella, D., HENKET, M., SCHLEICH, F., Dejong, T., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (June 2021). In vitro modelling of lung inflammatory processes [Paper presentation]. 18th international GcxGC symposium.

JACQUERIE, P., HENKET, M., André, B., MOERMANS, C., DE SENY, D., GESTER, F., LOUIS, R., MALAISE, M., & GUIOT, J. (21 May 2021). Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers. Scientific Reports, 11 (1), 10679. doi:10.1038/s41598-021-87701-1
Peer Reviewed verified by ORBi

Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Pojtewijd, J., SCHLEICH, F., Louis, R., & Focant, J.-F. (2021). Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03333-4
Peer Reviewed verified by ORBi

Moermans, C., Damas, K., Guiot, J., NJOCK, M.-S., Corhay, J.-L., Henket, M., Schleich, F., & Louis, R. (April 2021). Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype. Cytokine, 140, 155421. doi:10.1016/j.cyto.2021.155421
Peer Reviewed verified by ORBi

Schoneveld, L., LADANG, A., HENKET, M., Frix, A.-N., Cavalier, E., Guiot, J., MALAISE, O. (Other coll.), & LAMBERMONT, B. (Other coll.). (February 2021). YKL-40 as a new promising prognostic marker of severity in COVID infection. Critical Care, 25 (1), 66. doi:10.1186/s13054-020-03383-7
Peer reviewed

Stefanuto, P.-H., Zanella, D., Vercammen, J., HENKET, M., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2021). Asthma phenotyping using exhaled breath analysis and full-scan SIFT-MS data [Paper presentation]. MSACL annual meeting - virtual.

Guiot, J., HENKET, M., NJOCK, M.-S., MOERMANS, C., Struman, I., Corhay, J.-L., & Louis, R. (2021). La fibrose pulmonaire : des biomarqueurs à de nouveaux horizons thérapeutiques. Revue Médicale de Liège, 76 (3), 166-172.
Peer reviewed

Parzibut, G., Henket, M., Moermans, C., Struman, I., Louis, E., Malaise, M., Louis, R., Misset, B., NJOCK, M.-S.* , & Guiot, J.*. (2021). A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome. Frontiers in Molecular Biosciences, 8, 640042. doi:10.3389/fmolb.2021.640042
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

GUIOT, J., NJOCK, M.-S., ANDRE, B., GESTER, F., HENKET, M., DE SENY, D., MOERMANS, C., MALAISE, M., & LOUIS, R. (2021). Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction. Scientific Reports, 11 (1), 10882. doi:10.1038/s41598-021-90333-0
Peer Reviewed verified by ORBi

Darcis, G., Bouquegneau, A., Maes, N., Thys, M., Henket, M., Labye, F., Rousseau, A.-F., Canivet, P., Desir, C., Calmes, D., Schils, R., De Worm, S., Léonard, P., Meunier, P., Moutschen, M., Louis, R., & Guiot, J. (2021). Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, 109, 209-216. doi:10.1016/j.ijid.2021.07.016
Peer reviewed

Stefanuto, P.-H., Zanella, D., Schleich, F., Joeri, V., HENKET, M., LOUIS, R., & Focant, J.-F. (2021). Développement d'une approche multimodale pour le phénotypage de l'asthme sur base d'analyse d'air exhalé [Paper presentation]. 14 ème Congrès de l'Association Francophone des Sciences Séparatives, Paris, France.

GUIOT, J., Vaidyanathan, A., DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., THYS, M., HENKET, M., CANIVET, G., Mathieu, S., EFTAXIA, E., Lambin, P., Tsoutzidis, N., Miraglio, B., Walsh, S., Moutschen, M., Louis, R., Meunier, P., Vos, W., ... LOVINFOSSE, P. (2021). Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19. Diagnostics, 11 (1). doi:10.3390/diagnostics11010041
Peer reviewed

Schleich, F., Graff, S., GUISSARD, F., HENKET, M., Paulus, V., & Louis, R. (2021). Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping. Respiratory Research, 22 (1), 15. doi:10.1186/s12931-021-01619-w
Peer Reviewed verified by ORBi

Stefanuto, P.-H., Zanella, D., Joeri, V., HENKET, M., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2021). Exhaled breath analysis using full-scan SIFT-MS data: development of chemometric approaches and clinical potential [Paper presentation]. Anatune e-seminar.

Calmes, D., Huynen, P., Paulus, V., Henket, M., Guissard, F., Moermans, C., Louis, R., & Schleich, F. (2021). Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype. Respiratory Research, 22 (1), 72. doi:10.1186/s12931-021-01635-w
Peer Reviewed verified by ORBi

Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd, J., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2021). TD-GC×GC-HRTOFMS for Breath Profiling of Systemic Sclerosis. In Proceedings.
Peer reviewed

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x
Peer Reviewed verified by ORBi

Gerday, S., SCHLEICH, F., HENKET, M., GUISSARD, F., PAULUS, V., & LOUIS, R. (2021). Asthmatics with concordant eosinophilic disease classified according to their serum IgE status. Respiratory Medicine and Research. doi:10.1016/j.resmer.2020.100797
Peer Reviewed verified by ORBi

CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044
Peer Reviewed verified by ORBi

Graff, S., Zanella, D., Stefanuto, P.-H., HENKET, M., PAULUS, V., GUISSARD, F., MOERMANS, C., Van Steen, K., Louis, R., & Schleich, F. (2021). Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma? Journal of Asthma and Allergy, 14, 67-70. doi:10.2147/JAA.S289278
Peer Reviewed verified by ORBi

Graff, S., Bricmont, N., MOERMANS, C., HENKET, M., PAULUS, V., GUISSARD, F., LOUIS, R., & SCHLEICH, F. (2020). Clinical and biological factors associated with irreversible airway obstruction in adult asthma. Respiratory Medicine. doi:10.1016/j.rmed.2020.106202
Peer Reviewed verified by ORBi

Stefanuto, P.-H., Zanella, D., SCHLEICH, F., Joeri, V., Dejong, T., HENKET, M., LOUIS, R., & Focant, J.-F. (November 2020). Translating breath-based asthma phenotyping into clinical practice [Paper presentation]. Breath Biopsy Conference (online).

Frix, A.-N., Schoneveld, L., LADANG, A., HENKET, M., DUYSINX, B., VAILLANT, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., & Guiot, J. (November 2020). Could KL-6 levels in COVID-19 help to predict lung disease? Respiratory Research, 21 (309). doi:10.1186/s12931-020-01560-4
Peer Reviewed verified by ORBi

Radermecker, C., Detrembleur, N., Guiot, J., Cavalier, E., HENKET, M., D'Emal, C., Vanwinge, C., Cataldo, D., Oury, C., Delvenne, P., & Marichal, T. (November 2020). Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. Journal of Experimental Medicine, 217 (12). doi:10.1084/jem.20201012
Peer Reviewed verified by ORBi

Nekoee Zahraei, H., GUISSARD, F., Paulus, V., HENKET, M., Donneau, A.-F., & Louis, R. (2020). Comprehensive Cluster Analysis for COPD Including Systemic and Airway Inflammatory Markers. COPD: Journal of Chronic Obstructive Pulmonary Disease, 1-12. doi:10.1080/15412555.2020.1833853

Nekoee Zahraei, H., Graulich, E., SCHLEICH, F., GUISSARD, F., Paulus, V., HENKET, M., Donneau, A.-F., & Louis, R. (07 September 2020). Are T2 biomarkers of any help in asthma diagnosis? [Paper presentation]. ERS VIRTUAL CONGRESS 2020.

Parzibut, G., GUIOT, J., Misset, B., MALAISE, M., LOUIS, R., LOUIS, E., HENKET, M., MOERMANS, C., & NJOCK, M.-S. (September 2020). Alteration of Plasma Exosome Content in Acute Respiratory Distress Syndrome: a miRNA signature associated to lung fibrosing process [Poster presentation]. ERS International Congress 2020. doi:10.1183/13993003.congress-2020.3828

GUIOT, J., Cambier, M., Boeckx, A., HENKET, M., Nivelles, O., GESTER, F., LOUIS, E., MALAISE, M., Dequiedt, F., LOUIS, R., Struman, I.* , & NJOCK, M.-S.*. (05 August 2020). Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax, 75 (10), 870-881. doi:10.1136/thoraxjnl-2019-214077
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Nekoee Zahraei, H., Graulich, E., Schleich, F., GUISSARD, F., Paulus, V., HENKET, M., Donneau, A.-F., & Louis, R. (06 July 2020). Are type-2 biomarkers of any help in asthma diagnosis? [letter to the editor]. ERJ Open Research, 6. doi:10.1183/23120541.00169-2020
Peer Reviewed verified by ORBi

Zanella, D., HENKET, M., SCHLEICH, F., Dejong, T., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (2020). Comparison of the effect of chemically and biologically induced inflammation on the volatile metabolite production of lung epithelial cells by GC⨯GC-TOFMS. Analyst. doi:10.1039/d0an00720j
Peer Reviewed verified by ORBi

Stefanuto, P.-H., Zanella, D., SCHLEICH, F., Vercammen, J., HENKET, M., Dejong, T., Louis, R., & Focant, J.-F. (March 2020). Multimodal Approaches for Untargeted Screening for Medical Applications of the Human Volatilome [Paper presentation]. Pittcon 2020.

Louis, R., Bougard, N., GUISSARD, F., PAULUS, V., HENKET, M., & Schleich, F. (February 2020). Bronchodilation Test with Inhaled Salbutamol Versus Bronchial Methacholine Challenge to Make an Asthma Diagnosis: Do They Provide the Same Information? Journal of Allergy and Clinical Immunology: In Practice, 8 (2), 618-625.e8. doi:10.1016/j.jaip.2019.09.007
Peer Reviewed verified by ORBi

Guiot, J., HENKET, M., André, B., Herzog, M., Hardat, N., NJOCK, M.-S., MOERMANS, C., Malaise, M., & Louis, R. (2020). A new nucleosomic-based model to identify and diagnose SSc-ILD. Clinical Epigenetics, 12 (1), 124. doi:10.1186/s13148-020-00915-4
Peer Reviewed verified by ORBi

Stefanuto, P.-H., Zanella, D., SCHLEICH, F., Dejong, T., HENKET, M., LOUIS, R., & Focant, J.-F. (January 2020). Optimization of untargeted screening workflow for the characterization of lung fluid samples [Paper presentation]. 16th Hyphenated Technique in Chromatography Conference, Ghent, Belgium.

Stefanuto, P.-H., Zanella, D., Vercammen, J., HENKET, M., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2020). Multimodal combination of Gc × Gc‐HRtofMS and Sift‐MS for asthma phenotyping using exhaled breath. Scientific Reports, 10 (1016159). doi:10.1038/s41598-020-73408-2
Peer Reviewed verified by ORBi

SCHLEICH, F., Graff, S., Nekoee Zahraei, H., MOERMANS, C., HENKET, M., SANCHEZ, C., PAULUS, V., GUISSARD, F., Donneau, A.-F., & Louis, R. (2020). Real-word experience with mepolizumab: Does it deliver what it has promised? Clinical and Experimental Allergy. doi:10.1111/cea.13601
Peer Reviewed verified by ORBi

Louis, G., Pétré, B., SCHLEICH, F., HENKET, M., PAULUS, V., GUISSARD, F., LOUIS, R., & Guillaume, M. (2020). Relationship between quality of life and disordered physiology and cytology in asthma : a retrospective study from a secondary care center [Poster presentation]. Virtual ERS International Congress.

Frix, A.-N., Schleich, F., PAULUS, V., GUISSARD, F., HENKET, M., & Louis, R. (2020). Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma. Biochemical Pharmacology, 179. doi:10.1016/j.bcp.2020.113944
Peer Reviewed verified by ORBi

Gerday, S., SCHLEICH, F., HENKET, M., GUISSARD, F., PAULUS, V., & Louis, R. (2020). Comparison of demographic, functional and inflammatory features between atopic and non atopic asthmatics. Retrospective study on a large cohort of patients [Paper presentation]. ERS 2020 Virtual Congress.

GUIOT, J., HENKET, M., Frix, A.-N., Delvaux, M., DENIS, A., GILTAY, L., THYS, M., GESTER, F., MOUTSCHEN, M., CORHAY, J.-L., LOUIS, R., LAMBERMONT, B. (Other coll.), & MALAISE, O. (Other coll.). (2020). Single-center experience of patients with interstitial lung diseases during the early days of te COVID-19 pandemic. Respiratory Investigation, 58 (6), 437-9. doi:10.1016/j.resinv.2020.08.006
Peer Reviewed verified by ORBi

SIBILLE, A., HENKET, M., Corhay, J.-L., Louis, R., & DUYSINX, B. (2020). Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels [letter to the editor]. Acta Oncologica, 59 (3), 257-259. doi:10.1080/0284186X.2019.1695063
Peer Reviewed verified by ORBi

Peerboom, S., Graff, S., SEIDEL, L., PAULUS, V., HENKET, M., SANCHEZ, C., GUISSARD, F., MOERMANS, C., LOUIS, R., & SCHLEICH, F. (2020). Predictors of a good response to inhaled corticosteroids in obesity-associated asthma. Biochemical Pharmacology. doi:10.1016/j.bcp.2020.113994
Peer Reviewed verified by ORBi

Focant, J.-F., Zanella, D., HENKET, M., Dejong, T., SCHLEICH, F., LOUIS, R., & Stefanuto, P.-H. (January 2020). In vitro characterization of lung inflammation mechanisms [Paper presentation]. HTC-16, Ghent, Belgium.

Schleich, F., Frix, A.-N., Paulus, V., Guissard, F., Sanchez, C., Henket, M., & Louis, R. (2020). Une décennie d’avancées dans l’asthme : l’apport des biothérapies. Revue Médicale de Liège, 75 (5-6), 350-355.
Peer reviewed

MOERMANS, C., Deliege, E., Pirottin, D., Poulet, C., GUIOT, J., HENKET, M., & da Silva, J. (04 December 2019). Suitable reference genes determination for real-time PCR using induced sputum samples. European Respiratory Journal, 54 (6). doi:10.1183/13993003.00644-2018
Peer Reviewed verified by ORBi

Zanella, D., HENKET, M., SCHLEICH, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (October 2019). Multi-matrices screening for untargeted volatilomics by GC×GC-TOFMS. European Respiratory Journal. Supplement, 54, 4272. doi:10.1183/13993003.congress-2019.PA4272
Peer Reviewed verified by ORBi

Nekoee Zahraei, H., GUISSARD, F., PAULUS, V., HENKET, M., Donneau, A.-F., & Louis, R. (01 October 2019). Use of Principal Component and Cluster Analysis to Describe Phenotypes in COPD [Poster presentation]. ERS INTERNATIONAL CONGRESS 2019.

Zanella, D., Stefanuto, P.-H., Dejong, T., Fucito, M., HENKET, M., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (September 2019). GC×GC-TOFMS for in vitro and ex vivo Characterization of Lung Inflammation Mechanisms [Paper presentation]. SBSE 2019, Paris, France.

Graff, S., Demarche, S., HENKET, M., PAULUS, V., Louis, R., & SCHLEICH, F. (June 2019). Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma. Respiratory Medicine, 152, 60-66. doi:10.1016/j.rmed.2019.04.020
Peer Reviewed verified by ORBi

Arnone, M., Van Hulst, G., Desmet, C., Bureau, F., Jacobs, N., Gerday, S. (Other coll.), HENKET, M. (Other coll.), & LOUIS, R. (Other coll.). (21 May 2019). Building a comprehensive map of immune cell populations in sputum from patients with eosinophilic asthma [Poster presentation]. EDT-Immunology day.

Zanella, D., Dejong, T., SCHLEICH, F., HENKET, M., Louis, R., & Focant, J.-F. (13 May 2019). In vitro characterization of lung inflammation mechanisms [Poster presentation]. 43rd International Symposium on Capillary Chromatography & the 16th GCxGC Symposium, Fort Worth, Texas, United States.

Gerday, S., Schleich, F., Henket, M., GUISSARD, F., PAULUS, V., & Louis, R. (08 May 2019). Characterisation of a cohort of asthmatics with severe concordant eosinophilic disease according to their IgE status [Paper presentation]. GSK-SBP Pulmonology Award 2019.

Gerday, S., SCHLEICH, F., HENKET, M., GUISSARD, F., PAULUS, V., & Louis, R. (2019). Characterisation of a cohort of asthmatics with severe concordant eosinophilic disease according to their IgE status [Paper presentation]. ERS International Congress.

SCHLEICH, F., Zanella, D., Stefanuto, P.-H., Dallinga, J., HENKET, M., Wouters, E. F. M., Van Steen, K., Van Schooten, F., Focant, J.-F., & Louis, R. (2019). Exhaled Volatile Organic Compounds Are Able to Discriminate Between Neutrophilic and Eosinophilic Asthma. American Journal of Respiratory and Critical Care Medicine, 200 (4), 444-453. doi:10.1164/rccm.201811-2210OC
Peer Reviewed verified by ORBi

Nekoee Zahraei, H., PAULUS, V., HENKET, M., Louis, R., & Donneau, A.-F. (17 July 2018). Identification of Chronic Obstructive Pulmonary Disease Phenotype using PCA and Clustering Methodologies [Poster presentation]. 40th International Society for Clinical Biostatistics (ISCB40), Leuven, Belgium.

Njock, M.-S., GUIOT, J., HENKET, M., Nivelles, O., LOUIS, R., & Struman, I. (May 2018). Sputum exosomes - promising biomarkers for idiopathic pulmonary fibrosis [Poster presentation]. International Society for Extracellular Vesicles, Barcelone, Spain. doi:10.1080/20013078.2018.1461450

Demarche, S., SCHLEICH, F., HENKET, M., PAULUS, V., Louis, R., & Van Hees, T. (09 January 2018). Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life. Clinical and Experimental Allergy, 48 (5), 525-535. doi:10.1111/cea.13106
Peer Reviewed verified by ORBi

Njock, M.-S., GUIOT, J., HENKET, M., Nivelles, O., Thiry, M., Dequiedt, F., Corhay, J.-L., Louis, R., & Struman, I. (2018). Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis. Thorax. doi:10.1136/thoraxjnl-2018-211897
Peer Reviewed verified by ORBi

GUIOT, J., Demarche, S., HENKET, M., PAULUS, V., Graff, S., SCHLEICH, F., Corhay, J.-L., Louis, R., & MOERMANS, C. (2017). Methodology for Sputum Induction and Laboratory Processing. Journal of Visualized Experiments, (130). doi:10.3791/56612
Peer Reviewed verified by ORBi

GUIOT, J., CORHAY, J.-L., LOUIS, R., DUYSINX, B., SEIDEL, L., & HENKET, M. (2017). Clinical experience in idiopathic pulmonary fibrosis: a retrospective study. Acta Clinica Belgica. doi:10.1080/17843286.2017.1399228
Peer Reviewed verified by ORBi

Godinas, L., Corhay, J.-L., HENKET, M., GUIOT, J., Louis, R., & MOERMANS, C. (November 2017). Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction. Cytokine, 99, 1-8. doi:10.1016/j.cyto.2017.06.018
Peer Reviewed verified by ORBi

Qian, X., Aboushousha, R., van de Wetering, C., Chia, S. B., Amiel, E., Schneider, R. W., van der Velden, J. L. J., Lahue, K. G., Hoagland, D. A., Casey, D. T., Daphtary, N., Ather, J. L., Randall, M. J., Aliyeva, M., Black, K. E., Chapman, D. G., Lundblad, L. K. A., McMillan, D. H., Dixon, A. E., ... Janssen-Heininger, Y. M. W. (2017). IL-1/inhibitory kappaB kinase epsilon-induced glycolysis augment epithelial effector function and promote allergic airways disease. Journal of Allergy and Clinical Immunology. doi:10.1016/j.jaci.2017.08.043
Peer Reviewed verified by ORBi

GUIOT, J., Struman, I., CHAVEZ, V., HENKET, M., Herzog, M., Scoubeau, K., Hardat, N., Bondue, B., Corhay, J.-L., MOERMANS, C., & Louis, R. (15 August 2017). Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis. Clinical Epigenetics, 9, 84. doi:10.1186/s13148-017-0383-x
Peer Reviewed verified by ORBi

Demarche, S., SCHLEICH, F., HENKET, M., PAULUS, V., Van Hees, T., & Louis, R. (May 2017). How to Approach Eosinophilic Versus Non-eosinophilic Asthma in Clinical Practice Using Biomarkers? [Poster presentation]. American Thoracic Society International Conference 2017, Washington DC, United States.

GUIOT, J., Moermans, C., HENKET, M., Corhay, J.-L., & Louis, R. (2017). Blood Biomarkers in Idiopathic Pulmonary Fibrosis. Lung. doi:10.1007/s00408-017-9993-5
Peer Reviewed verified by ORBi

GUIOT, J., HENKET, M., Corhay, J.-L., Moermans, C., & Louis, R. (08 February 2017). Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7. PLoS ONE, 12 (2), 0171344. doi:10.1371/journal.pone.0171344
Peer Reviewed verified by ORBi

Demarche, S., Schleich, F., PAULUS, V., HENKET, M., Van Hees, T., & Louis, R. (2017). Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers? [letter to the editor]. Respiratory Research, 18 (1), 133-139. doi:10.1186/s12931-017-0615-9
Peer Reviewed verified by ORBi

Demarche, S., SCHLEICH, F., PAULUS, V., HENKET, M., Van Hees, T., & Louis, R. (2017). Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice. Journal of Allergy and Clinical Immunology: In Practice, 5 (5), 1335-1343.e5. doi:10.1016/j.jaip.2017.01.026
Peer Reviewed verified by ORBi

Demarche, S., Schleich, F., HENKET, M., PAULUS, V., Van Hees, T., & Louis, R. (2017). Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre. BMJ Open, 7 (11), 018186. doi:10.1136/bmjopen-2017-018186
Peer Reviewed verified by ORBi

Mesnil, C., Raulier, S., Paulissen, G., Xiao, X., Birrell, M., Pirottin, D., Janss, T., Starkl, P., Ramery, E., HENKET, M., SCHLEICH, F., Radermecker, M., Thielemans, K., Gillet, L., Thiry, M., Belvisi, M., LOUIS, R., Desmet, C., Marichal, T., & Bureau, F. (21 October 2016). Lung resident eosinophils represent a distinct cell subset with homeostatic functions [Paper presentation]. FARAH Day 2016, Liege, Belgium.

da Silva, J., Hilzendeger, C., Moermans, C., SCHLEICH, F., HENKET, M., Kebadze, T., Mallia, P., Edwards, I. J., Johnston, S. L., & Louis, R. (2016). Raised interferon beta, type 3 interferon and interferon stimulated genes - evidence of innate immune activation in neutrophilic asthma. Clinical and Experimental Allergy. doi:10.1111/cea.12809
Peer reviewed

GUIOT, J., HENKET, M., BONDUE, B., CORHAY, J.-L., & LOUIS, R. (September 2016). IGFBP-2 a new interesting target in IPF [Paper presentation]. ERS Congress. doi:10.1183/13993003.congress-2016.PA3092

Hilzendeger, C., da Silva, J., HENKET, M., SCHLEICH, F., CORHAY, J.-L., Kebadze, T., Edwards, M. R., Mallia, P., Johnston, S. L., & Louis, R. (30 June 2016). Reduced sputum expression of interferon-stimulated genes in severe COPD. International Journal of Chronic Obstructive Pulmonary Disease, 11, 1485-94. doi:10.2147/COPD.S105948
Peer Reviewed verified by ORBi

GUIOT, J., Bondue, B., HENKET, M., CORHAY, J.-L., & LOUIS, R. (23 May 2016). Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis. BMC Pulmonary Medicine, 16 (1), 86. doi:10.1186/s12890-016-0249-6
Peer Reviewed verified by ORBi

Maes, T., Cobos, F. A., SCHLEICH, F., Sorbello, V., HENKET, M., De Preter, K., Bracke, K. R., Conickx, G., Mesnil, C., Vandesompele, J., Lahousse, L., Bureau, F., Mestdagh, P., Joos, G. F., Ricciardolo, F. L. M., Brusselle, G. G., & LOUIS, R. (May 2016). Asthma inflammatory phenotypes show differential microRNA expression in sputum. Journal of Allergy and Clinical Immunology, 137 (5), 1433-46. doi:10.1016/j.jaci.2016.02.018
Peer Reviewed verified by ORBi

Demarche, S., SCHLEICH, F., HENKET, M., PAULUS, V., VAN HEES, T., & LOUIS, R. (05 April 2016). Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory? BMC Pulmonary Medicine, 16, 46. doi:10.1186/s12890-016-0208-2
Peer Reviewed verified by ORBi

SCHLEICH, F., Dallinga, J. W., HENKET, M., Wouters, E. F. M., Louis, R., & Van Schooten, F. J. (01 February 2016). Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammation in vitro. Journal of Breath Research, 10 (1), 016006. doi:10.1088/1752-7155/10/1/016006
Peer Reviewed verified by ORBi

Mesnil, C.* , Raulier, S.* , Paulissen, G., Xiao, X., Birrell, M., Pirottin, D., Janss, T., Starkl, P., Ramery, E., HENKET, M., SCHLEICH, F., Radermecker, C., Thielemans, K., Gillet, L., Thiry, M., Belvisi, M., Louis, R., Desmet, C., Marichal, T.* , & Bureau, F.*. (2016). Lung-resident eosinophils represent a distinct regulatory eosinophil subset. Journal of Clinical Investigation, 126 (9), 3275-3295. doi:10.1172/JCI85664
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Mouthuy, J., Viart, S., Ladjemi, M. Z., Detry, B., HENKET, M., Bachert, C., Louis, R., & Pilette, C. (December 2015). Mite allergen-specific IgE is detectable in bronchial secretions of patients with nonatopic asthma and correlates with mucosal expression of periostin. Journal of Allergy and Clinical Immunology, 136 (6), 1685-8.e1-2. doi:10.1016/j.jaci.2015.07.018
Peer Reviewed verified by ORBi

Demarche, S., SCHLEICH, F., HENKET, M., PAULUS, V., Van Hees, T., & Louis, R. (27 September 2015). Asthma Control and Sputum Eosinophils: a Longitudinal Study in Daily Practice [Poster presentation]. ERS Amsterdam 2015 International Congress, Amsterdam, Netherlands.

Demarche, S., SCHLEICH, F., HENKET, M., PAULUS, V., Van Hees, T., & Louis, R. (12 June 2015). Asthma Control and Sputum Eosinophils: a Longitudinal Study in Daily Practice [Paper presentation]. AIRe WAY II, 3th annual scientific meeting.

Demarche, S., SCHLEICH, F., HENKET, M., PAULUS, V., VAN HEES, T., & LOUIS, R. (02 June 2015). Asthma Control and Sputum Eosinophils: a Longitudinal Study in Daily Practice [Poster presentation]. Biomedica Summit 2015.

GUIOT, J., HENKET, M., CORHAY, J.-L., & LOUIS, R. (2015). Serum Insulin - like Growth Factor B inding P rotein 2 (IGFBP2) as a m arker of Idiopathic Pulmonary F ibrosis [Poster presentation]. Biomedica.

GUIOT, J., HENKET, M., CORHAY, J.-L., & LOUIS, R. (2015). Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis [Poster presentation]. ERS congress. doi:10.1183/13993003.congress-2015.PA3840

MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164
Peer Reviewed verified by ORBi

Corhay, J.-L., MOERMANS, C., HENKET, M., NGUYEN DANG, D., DUYSINX, B., & Louis, R. (28 September 2014). Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD. Respiratory Research, 15, 115. doi:10.1186/s12931-014-0115-0
Peer Reviewed verified by ORBi

MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068
Peer Reviewed verified by ORBi

SCHLEICH, F., Chevremont, A., PAULUS, V., HENKET, M., Manise, M., Seidel, L., & Louis, R. (2014). Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. European Respiratory Journal, 44, 97-108. doi:10.1183/09031936.00201813
Peer Reviewed verified by ORBi

EL SHAZLY, A., Begon, D., KUSTERMANS, G., Arafa, M., Dortu, E., HENKET, M., Lefèbvre, P., Louis, R., & Delvenne, P. (2013). Novel association between vasoactive intestinal peptide and CRTH2 receptor in recruiting eosinophils: a possible biochemical mechanism for allergic eosinophilic inflammation of the airways. Journal of Biological Chemistry, 288 (2), 1374-84. doi:10.1074/jbc.M112.422675
Peer Reviewed verified by ORBi

SCHLEICH, F., Manise, M., Sele, J., HENKET, M., Seidel, L., & LOUIS, R. (2013). Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulmonary Medicine, 13 (1), 11. doi:10.1186/1471-2466-13-11
Peer Reviewed verified by ORBi

Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013
Peer Reviewed verified by ORBi

MANISE, M., SCHLEICH, F., QUAEDVLIEG, V., Moermans, C., HENKET, M., SELE, J., CORHAY, J.-L., & LOUIS, R. (2012). Disturbed Cytokine Production at the Systemic Level in Difficult-to-Control Atopic Asthma: Evidence for Raised Interleukin-4 and Decreased Interferon-gamma Release following Lipopolysaccharide Stimulation. International Archives of Allergy and Immunology, 158 (1), 1-8. doi:10.1159/000329858
Peer Reviewed verified by ORBi

El-Shazly, A., HENKET, M., Lefèbvre, P., & LOUIS, R. (2011). 2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge. International Journal of Immunopathology and Pharmacology, 24 (4), 949-60. doi:10.1177/039463201102400413
Peer Reviewed verified by ORBi

Moermans, C., HEINEN, V., NGUYEN DANG, D., HENKET, M., SELE, J., Manise, M., Corhay, J.-L., & Louis, R. (2011). Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine, 56 (2), 298-304. doi:10.1016/j.cyto.2011.07.010
Peer Reviewed verified by ORBi

DUYSINX, B., PAULUS, A., HEINEN, V., NGUYEN DANG, D., HENKET, M., CORHAY, J.-L., & Louis, R. (2011). Diagnostic value of neurotrophin expression in malignant pleural effusions. Experimental and Therapeutic Medicine, 2 (5), 941-946. doi:10.3892/etm.2011.302
Peer Reviewed verified by ORBi

EL SHAZLY, A., MOONEN, V., MAWET, M., Begon, D., HENKET, M., Arafa, M., LOUIS, R., Delvenne, P., & LEFEBVRE, P. (2011). IFN-gamma and TNF-alpha potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. International Immunopharmacology, 11 (11), 1864-70. doi:10.1016/j.intimp.2011.07.017
Peer Reviewed verified by ORBi

Manise, M., Schleich, F., Gusbin, N., Godinas, L., Henket, M., Antoine, N., Corhay, J.-L., & Louis, R. (2010). Cytokine production from sputum cells and blood leukocytes in asthmatics according to disease severity. Allergy, 65 (7), 889-96. doi:10.1111/j.1398-9995.2009.02296.x
Peer Reviewed verified by ORBi

Corhay, J.-L., Henket, M., Nguyen Dang, D., Duysinx, B., Sele, J., & Louis, R. (2009). Leukotriene B4 Contributes to Exhaled Breath Condensate and Sputum Neutrophil Chemotaxis in COPD. CHEST, 136 (4), 1047-1054. doi:10.1378/chest.08-2782
Peer Reviewed verified by ORBi

Quaedvlieg, V., Sele, J., Henket, M., & Louis, R. (2009). Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice. Clinical and Experimental Allergy, 39, 1822-1829. doi:10.1111/j.1365-2222.2009.03332.x
Peer Reviewed verified by ORBi

Duysinx, B., Corhay, J.-L., Hubin, L., Nguyen Dang, D., Henket, M., & Louis, R. (2008). Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions. Respiratory Medicine, 102 (12), 1708-14. doi:10.1016/j.rmed.2008.07.008
Peer Reviewed verified by ORBi

Corhay, J.-L., Hemelaers, Henket, M., Sele, J., & Louis, R. (June 2007). Granulocyte chemotactic activity in exhaled breath condensate of healthy subjects and patients with COPD. CHEST, 131 (6), 1672-1677. doi:10.1378/chest.06-2225
Peer Reviewed verified by ORBi

Dentener, M. A., Louis, R., Cloots, R. H. E., Henket, M., & Wouters, E. F. M. (June 2006). Differences in local versus systemic TNF alpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNF alpha release. Thorax, 61 (6), 478-484. doi:10.1136/thx.2005.053330
Peer Reviewed verified by ORBi

Hemelaers, L., Henket, M., Sele, J., Bureau, F., & Louis, R. (January 2006). Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Allergy, 61 (1), 136-139. doi:10.1111/j.1398-9995.2006.00993.x
Peer Reviewed verified by ORBi

Quaedvlieg, V., Henket, M., Sele, J., & Louis, R. (January 2006). Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clinical and Experimental Immunology, 143 (1), 161-166. doi:10.1111/j.1365-2249.2005.02968.x
Peer Reviewed verified by ORBi

Delvaux, M., Henket, M., Lau, L., Kange, P., Bartsch, P., Djukanovic, R., & Louis, R. (01 February 2004). Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax, 59 (2), 111-115. doi:10.1136/thorax.2003.011130
Peer Reviewed verified by ORBi

Bettiol, J., Sele, J., Henket, M., Louis, E., Malaise, M., Bartsch, P., & Louis, R. (December 2002). Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy, 57 (12), 1145-1150. doi:10.1034/j.1398-9995.2002.23586.x
Peer Reviewed verified by ORBi

Louis, R., Sele, J., Henket, M., Cataldo, D., Bettiol, J., Seiden, L., & Bartsch, P. (October 2002). Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy, 57 (10), 907-912. doi:10.1034/j.1398-9995.2002.23608.x
Peer Reviewed verified by ORBi

Louis, R., Cataldo, D., Buckley, M. G., Sele, J., Henket, M., Lau, L. C., Bartsch, P., Walls, A. F., & Djukanovic, R. (August 2002). Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. European Respiratory Journal, 20 (2), 325-331. doi:10.1183/09031936.02.00286302
Peer Reviewed verified by ORBi

Contact ORBi